Transforming Growth Factor Beta (TFG-β) Concentration Isoforms are Diminished in Acute Coronary Syndrome
Acute coronary syndrome (ACS) is the leading cause of death in elderly patients worldwide. Due its participation in apoptosis, fibrosis, and angiogenesis, transforming growth factor-β (TGF-β) isoforms had been categorized as risk factors for cardiovascular diseases. However, due their contradictory activities, a cardioprotective role has been suggested. The aim was to measure the plasma levels of TGF-β1, 2, and 3 proteins in patients with ACS. This was a case–control study including 225 subjects. The three activated isoforms were measured in serum using the Bio-Plex Pro TGF-β assay by means of magnetic beads; the fluorescence intensity of reporter signal was read in a Bio-Plex Magpix instrument. We observed a significant reduction of the three activated isoforms of TGF-β in patients with ACS. The three TGF-β isoforms were positively correlated with each other in moderate-to-strong manner. TGFβ-2 was inversely correlated with glucose and low-density lipoprotein (LDL)-cholesterol, whereas TGF-β3 was inversely correlated with the serum cholesterol concentration. The production of TGF-β1, TGF-β2, and TGF-β3 are decreased in the serum of patients with ACS. Further follow-up controlled studies with a larger sample size are needed, in order to test whether TGF-β isoforms could be useful as biomarkers that complement the diagnosis of ACS.
KeywordsAcute coronary syndrome Protein isoforms Serum concentration TGF-β concentration Cardiac diseases
The authors thank all of the participants in this study
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 5.Heldin C.-H., Moustakas A. (2016) Signaling receptors for TGF-β family members. Cold Spring Harbor Perspectives in Biology, 8, 22–53.Google Scholar
- 6.Accornero, F., van Berlo, J. H., Correll, R. N., Elrod, J. W., Sargent, M. A., & York, A., et al. (2015). Genetic analysis of connective tissue growth factor as an effector of transforming growth factor β signaling and cardiac remodeling. Molecular and Cellular Biology, 35, 2154–2164.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Ohtsuka, K., Gray, J. D., Stimmler, M. M., Toro, B., & Horwitz, D. A. (1998). Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol Baltimore Maryland 1950, 160, 2539–2545.Google Scholar
- 20.Liu, Y., Yuan, X., Li, W., Cao, Q., & Shu, Y. (2016). Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress. International Journal of Molecular Medicine, 38, 1235–1242.CrossRefPubMedGoogle Scholar
- 22.Schaan, B. D., Quadros, A. S., Sarmento-Leite, R., De Lucca, G., Bender, A., & Bertoluci, M. (2007). “Correction:” Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease. Cardiovascular Diabetology, 6, 19.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Madrid-Miller, A., Chávez-Sánchez, L., Careaga-Reyna, G., Borrayo-Sánchez, G., Chávez-Rueda, K., & Montoya-Guerrero, S. A., et al. (2014). Clinical outcome in patients with acute coronary syndrome and outward remodeling is associated with a predominant inflammatory response. BMC Research Notes, 7, 669.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Okada, H., Takemura, G., Kosai, K., Li, Y., Takahashi, T., & Esaki, M., et al. (2005). Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation, 111, 2430–2437.CrossRefPubMedGoogle Scholar
- 30.Bugyei-Twum, A., Advani, A., Advani, S. L., Zhang, Y., Thai, K., & Kelly, D. J., et al. (2014). High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy. Cardiovascular diabetology, 13, 89.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Han, J., Hajjar, D. P., Tauras, J. M., Feng, J., Gotto, A. M., & Nicholson, A. C. (2000). Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. The Journal of Biological Chemistry, 275, 1241–1246.CrossRefPubMedGoogle Scholar